№16 (210) / 2010

V.V. Fomin
M.B. Antsiferov, A.V. Zilov
Potentials For Use Of Dipeptidyl Peptidase-4 Inhibitors In Type 2 Diabetes Mellitus: Initiation And Continuation Of Therapy 		12-17
T.Yu. Demidova
Etiopthogenic Role Of Insulin Resistance In The Development Of Metabolic And Vascular Disorders In Type 2 Diabetes Mellitus 		18-24
I.V. Gur’eva
Therapeutic Potentials Of Benfotiamine 		26-30
A.M. Mkrtumyan
Saxagliptin Opens New Opportunities For Effective And Safe Glycemic Control In Patients With Type 2 Diabetes Mellitus 		32-36
M.B. Antsiferov, O.M. Koteshkova, S.A. Kleimenova
Continuous Subcutaneous Insulin Infusion: Effective Method For Control Of Type 1 Diabetes Mellitus 		38-45
Ye.V. Biryukova
Insulin Treatment Of Type 2 Diabetes Mellitus: A Choice And An Individual Approach 		46-52
N.A. Petunina
When To Begin Combined Therapy Of Type 2 Diabetes Mellitus 		53-59
M.B. Antsiferov, L.Yu. Morgunov, N.A. Demidov, I.V. Volokitin
Potentials For Use Of Dipeptidyl Peptidase-4 Inhibitors In Type 2 Diabetes Mellitus: Initiation And Continuation Of Therapy 		60-66
A.F.Verbovoy, I.A. Fomina
Endocrine-metabolic Indices And Leptin In Young Men With Obesity, Manifesting In Puberty 		68-70
A.V. Rudakova
Pharmacoeconomic Aspects Of Use Of Sulfonylurea Medications In Insulin-independent Diabetes 		71-72
O.V. Zanozina
Possibility Of Correction Of Oxidative Stress In Patients With Diabetes Using Dibicor 		73-76
Richard M. Bergenstal, M.D., William V. Tamborlane, M.D., Andrew Ahmann, M.D., John B. Buse, M.D., Ph.D., George Dailey, M.D., Stephen N. Davis, M.D., Carol Joyce, M.D., Tim Peoples, M.A., Bruce A. Perkins, M.D., M.P.H., John B. Welsh, M.D., Ph.D., Steven M. Willi, M.D., and Michael A. Wood, M.D., for the STAR 3 Study Group
* 		77-86
A.Yu Mayorov, Ye.V. Surkova, I.I. Dedov
Assessment Of Efficacy Of Education Of General Practitioners By The Training Program For Management Of Type 2 Diabetes Mellitus 		87-92
I. Samylina, A. Sorokina, N. Pyatigorskaya
Ginseng (Panax ginseng C.A. Mey) 		93-95

Бионика Медиа